IRIS Accounts Production v24.2.0.383 12570252 director 1.9.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh125702522023-08-31125702522024-03-31125702522023-09-012024-03-31125702522022-08-31125702522022-09-012023-08-31125702522023-08-3112570252ns15:EnglandWales2023-09-012024-03-3112570252ns14:PoundSterling2023-09-012024-03-3112570252ns10:Director12023-09-012024-03-3112570252ns10:PrivateLimitedCompanyLtd2023-09-012024-03-3112570252ns10:SmallEntities2023-09-012024-03-3112570252ns10:AuditExempt-NoAccountantsReport2023-09-012024-03-3112570252ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-03-3112570252ns10:SmallCompaniesRegimeForAccounts2023-09-012024-03-3112570252ns10:FullAccounts2023-09-012024-03-3112570252ns10:RegisteredOffice2023-09-012024-03-3112570252ns5:CurrentFinancialInstruments2024-03-3112570252ns5:CurrentFinancialInstruments2023-08-3112570252ns5:ShareCapital2024-03-3112570252ns5:ShareCapital2023-08-3112570252ns5:RetainedEarningsAccumulatedLosses2024-03-3112570252ns5:RetainedEarningsAccumulatedLosses2023-08-3112570252ns5:FurnitureFittings2023-09-012024-03-3112570252ns5:ComputerEquipment2023-09-012024-03-3112570252ns5:FurnitureFittings2023-08-3112570252ns5:ComputerEquipment2023-08-3112570252ns5:FurnitureFittings2024-03-3112570252ns5:ComputerEquipment2024-03-3112570252ns5:FurnitureFittings2023-08-3112570252ns5:ComputerEquipment2023-08-3112570252ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3112570252ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-08-31
REGISTERED NUMBER: 12570252 (England and Wales)


























UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1ST SEPTEMBER 2023 TO 31ST MARCH 2024

FOR

CHEQUP HEALTH LIMITED

CHEQUP HEALTH LIMITED (REGISTERED NUMBER: 12570252)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1ST SEPTEMBER 2023 TO 31ST MARCH 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


CHEQUP HEALTH LIMITED

COMPANY INFORMATION
FOR THE PERIOD 1ST SEPTEMBER 2023 TO 31ST MARCH 2024







DIRECTOR: Mr T C D Nicol





REGISTERED OFFICE: Clifton House
Bunnian Place
Basingstoke
Hampshire
RG21 7JE





REGISTERED NUMBER: 12570252 (England and Wales)






CHEQUP HEALTH LIMITED (REGISTERED NUMBER: 12570252)

BALANCE SHEET
31ST MARCH 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,904 8,047

CURRENT ASSETS
Debtors 5 14,415 269
Cash at bank 15,802 6,340
30,217 6,609
CREDITORS
Amounts falling due within one year 6 399,033 351,779
NET CURRENT LIABILITIES (368,816 ) (345,170 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(364,912

)

(337,123

)

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (365,012 ) (337,223 )
(364,912 ) (337,123 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 6th September 2024 and were signed by:





Mr T C D Nicol - Director


CHEQUP HEALTH LIMITED (REGISTERED NUMBER: 12570252)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1ST SEPTEMBER 2023 TO 31ST MARCH 2024


1. STATUTORY INFORMATION

Chequp Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
In respect of long-term contracts and contracts for on-going services, turnover represents the value of work done in the year, including estimates of amounts not invoiced. Turnover in respect of long-term contracts and contracts for on-going services is recognised by reference to the stage of completion.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% straight line
Computer equipment - 33% straight line

All fixed assets are initially recorded at cost.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

CHEQUP HEALTH LIMITED (REGISTERED NUMBER: 12570252)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1ST SEPTEMBER 2023 TO 31ST MARCH 2024


2. ACCOUNTING POLICIES - continued

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Operating lease agreements
Rentals applicable to operating leases where substantially all of the benefits and risks of ownership remain with the lessor are charged against profits on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1st September 2023
and 31st March 2024 9,269 7,923 17,192
DEPRECIATION
At 1st September 2023 4,816 4,329 9,145
Charge for period 1,854 2,289 4,143
At 31st March 2024 6,670 6,618 13,288
NET BOOK VALUE
At 31st March 2024 2,599 1,305 3,904
At 31st August 2023 4,453 3,594 8,047

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 14,415 269

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts - 77,076
Trade creditors 35,990 14,757
Taxation and social security 20,730 18,036
Other creditors 342,313 241,910
399,033 351,779